Alexandra G. Brunasso-Gulia
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis).
Journal: Dermatology and therapy
Published: December 26, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis).
Journal: Dermatology practical & conceptual
Published: March 06, 2025
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study - IL PSO (Italian Landscape Psoriasis).
Journal: The Journal of dermatological treatment
Published: February 06, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: January 17, 2025
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' Lives.
Journal: Dermatology practical & conceptual
Published: January 17, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).
Journal: Journal of clinical medicine
Published: December 31, 2024
Does the response to bimekizumab vary according to previous therapy with methotrexate versus cyclosporine?
Journal: Dermatology reports
Published: December 23, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 22, 2024
Improvement of self-administration experience with a new injection device: Real-life experience with risankizumab in patients with psoriasis.
Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Published: July 10, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.
Journal: Journal of clinical medicine
Published: November 24, 2023
Risankizumab: Daily Practice Experience of High Need Patients.
Journal: Biomedicines
Published: April 06, 2023
Nail Psoriasis Improvement During Tildrakizumab Therapy: A Real-Life Experience.
Journal: Journal of drugs in dermatology : JDD
Published: August 10, 2022
Last Updated: 09/26/2026